These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
603 related items for PubMed ID: 18984024
1. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G. Vaccine; 2009 Jan 07; 27(2):328-35. PubMed ID: 18984024 [Abstract] [Full Text] [Related]
2. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV, Biswas S, Pillai CR, Saxena RK. Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786 [Abstract] [Full Text] [Related]
4. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei. Bergmann-Leitner ES, Duncan EH, Leitner WW, Neutzner A, Savranskaya T, Angov E, Tsokos GC. Vaccine; 2007 Nov 07; 25(45):7732-6. PubMed ID: 17931754 [Abstract] [Full Text] [Related]
5. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Flueck C, Frank G, Smith T, Jafarshad A, Nebie I, Sirima SB, Olugbile S, Alonso P, Tanner M, Druilhe P, Felger I, Corradin G. Vaccine; 2009 May 05; 27(20):2653-61. PubMed ID: 19428875 [Abstract] [Full Text] [Related]
7. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. Dobaño C, Doolan DL. Mol Immunol; 2007 Apr 05; 44(11):3037-48. PubMed ID: 17303242 [Abstract] [Full Text] [Related]
8. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria. Yadava A, Nurmukhambetova S, Pichugin AV, Lumsden JM. J Infect Dis; 2012 May 01; 205(9):1456-63. PubMed ID: 22457289 [Abstract] [Full Text] [Related]
12. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region. Das P, Grewal JS, Mahajan B, Chauhan VS. Parasitol Int; 2007 Mar 01; 56(1):51-9. PubMed ID: 17258500 [Abstract] [Full Text] [Related]
13. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria. Pratt-Riccio LR, Lima-Junior JC, Carvalho LJ, Theisen M, Espíndola-Mendes EC, Santos F, Oliveira-Ferreira J, Goldberg AC, Daniel-Ribeiro CT, Banic DM. Am J Trop Med Hyg; 2005 Dec 01; 73(6):1096-103. PubMed ID: 16354819 [Abstract] [Full Text] [Related]
18. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? Nebie I, Tiono AB, Diallo DA, Samandoulougou S, Diarra A, Konate AT, Cuzin-Ouattara N, Theisen M, Corradin G, Cousens S, Ouattara AS, Ilboudo-Sanogo E, Sirima BS. Trop Med Int Health; 2008 Feb 01; 13(2):229-37. PubMed ID: 18304269 [Abstract] [Full Text] [Related]